within Pharmacolibrary.Drugs.ATC.L;

model L01XG01
  extends Pharmacokinetic.Models.PK_3C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0017,
    adminDuration  = 600,
    adminMass      = 1.3 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.498,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>L01XG01</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>3</td></tr></table><p>Bortezomib is a reversible proteasome inhibitor used primarily in the treatment of multiple myeloma and mantle cell lymphoma. It is administered parenterally and is FDA-approved for clinical use.</p><h4>Pharmacokinetics</h4><p>Healthy adult patients and patients with multiple myeloma, intravenous bolus administration.</p><h4>References</h4><ol><li><p>Tan, CRC, et al., &amp; Barta, SK (2019). Clinical Pharmacokinetics and Pharmacodynamics of Bortezomib. <i>Clinical pharmacokinetics</i> 58(2) 157–168. DOI:<a href=\"https://doi.org/10.1007/s40262-018-0679-9\">10.1007/s40262-018-0679-9</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29802543/\">https://pubmed.ncbi.nlm.nih.gov/29802543</a></p></li><li><p>Barta, SK, et al., &amp; Braunschweig, I (2017). Pharmacokinetics-directed Intravenous Busulfan Combined With High-dose Melphalan and Bortezomib as a Conditioning Regimen for Patients With Multiple Myeloma. <i>Clinical lymphoma, myeloma &amp; leukemia</i> 17(10) 650–657. DOI:<a href=\"https://doi.org/10.1016/j.clml.2017.06.005\">10.1016/j.clml.2017.06.005</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28684379/\">https://pubmed.ncbi.nlm.nih.gov/28684379</a></p></li><li><p>Leveque, D (2014). Subcutaneous administration of anticancer agents. <i>Anticancer research</i> 34(4) 1579–1586. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24692685/\">https://pubmed.ncbi.nlm.nih.gov/24692685</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end L01XG01;
